540 related articles for article (PubMed ID: 18288733)
1. Percutaneous transcatheter closure of patent foramen ovale with the Amplatzer Cribriform septal occluder.
Silvestry FE; Naseer N; Wiegers SE; Hirshfeld JW; Herrmann HC
Catheter Cardiovasc Interv; 2008 Feb; 71(3):383-7. PubMed ID: 18288733
[TBL] [Abstract][Full Text] [Related]
2. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
[TBL] [Abstract][Full Text] [Related]
3. ASD and PFO closure with the Solysafe septal occluder - results of a prospective multicenter pilot study.
Ewert P; Söderberg B; Dähnert I; Hess O; Schuler G; Bussmann C; Bernhard J; Sick P
Catheter Cardiovasc Interv; 2008 Feb; 71(3):398-402. PubMed ID: 18288739
[TBL] [Abstract][Full Text] [Related]
4. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
[TBL] [Abstract][Full Text] [Related]
5. New onset atrial fibrillation after patent foramen ovale closure.
Staubach S; Steinberg DH; Zimmermann W; Wawra N; Wilson N; Wunderlich N; Sievert H
Catheter Cardiovasc Interv; 2009 Nov; 74(6):889-95. PubMed ID: 19626689
[TBL] [Abstract][Full Text] [Related]
6. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
[TBL] [Abstract][Full Text] [Related]
7. Early experience with a simplified technique for transcatheter closure of the patent foramen ovale.
Kutty S; Nykanen DG; Zahn EM
Heart Lung Circ; 2009 Dec; 18(6):384-7. PubMed ID: 19783211
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial.
Hong TE; Thaler D; Brorson J; Heitschmidt M; Hijazi ZM;
Catheter Cardiovasc Interv; 2003 Dec; 60(4):524-8. PubMed ID: 14624434
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems.
Braun M; Gliech V; Boscheri A; Schoen S; Gahn G; Reichmann H; Haass M; Schraeder R; Strasser RH
Eur Heart J; 2004 Mar; 25(5):424-30. PubMed ID: 15033255
[TBL] [Abstract][Full Text] [Related]
11. Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.
Kutty S; Brown K; Asnes JD; Rhodes JF; Latson LA
Am J Cardiol; 2008 May; 101(10):1487-92. PubMed ID: 18471463
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R
Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959
[TBL] [Abstract][Full Text] [Related]
13. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
[TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure.
Johnson JN; Marquardt ML; Ackerman MJ; Asirvatham SJ; Reeder GS; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2011 Aug; 78(2):254-61. PubMed ID: 21563292
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter closure of patent foramen ovale with the Spider patent foramen ovale occluder: a prospective, single-center trial.
Zhang CJ; Huang YG; Huang XS; Huang T; Huang WH; Shen JJ; Xun ZR
Chin Med J (Engl); 2010 Apr; 123(7):834-7. PubMed ID: 20497673
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter patent foramen ovale closure in spite of interatrial septum hypertrophy or lipomatosis: a case series.
Rigatelli G; Dell'Avvocata F; Giordan M; Ronco F; Braggion G; Schenal N; Aggio S; Cardaioli P
J Cardiovasc Med (Hagerstown); 2010 Feb; 11(2):91-5. PubMed ID: 19829139
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.
Mansencal N; Mitry E; Pillière R; Lepère C; Gérardin B; Petit J; Gandjbakhch I; Rougier P; Dubourg O
Am J Cardiol; 2008 Apr; 101(7):1035-8. PubMed ID: 18359327
[TBL] [Abstract][Full Text] [Related]
18. PFO closure devices: The disconnect between technology, technique, and indications for use.
Feldman T
Catheter Cardiovasc Interv; 2008 Feb; 71(3):403-4. PubMed ID: 18288746
[No Abstract] [Full Text] [Related]
19. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
[TBL] [Abstract][Full Text] [Related]
20. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
